Promakhos Therapeutics

Private Company

Creating transformative medicines for patients with inflammatory diseases.

Biotechnology Research
Boston, Massachusetts
2-10 employees
Founded 2021

About Promakhos Therapeutics

Promakhos Therapeutics is a biotechnology company developing transformative medicines for people with inflammatory diseases. Their therapies aim to address the root cause of conditions like Crohn's disease and multiple sclerosis by restoring the immune system's natural ability to manage inflammation and heal. The company targets both patients suffering from these chronic conditions and partners within the biomedical research and pharmaceutical industries.

Company Classification

Customer Types
B2B
Business Models
ProductsLicensing
Product & Service Types
Immune-restorative therapiesTreatments for inflammatory diseases

Customers

CustomerSuccess StorySource
Promakhos Therapeutics
Promakhos Therapeutics joined the Harvard Venture Program as a new Venture Team for Spring 2021, participating in the Build It track for Health & Sciences.
Promakhos Therapeutics
Participated in the final showcase event of the MassBIO® MassCONNECT® program Cycle I 2021.
Nice Try
Sign up to Ethos to access the full customer list
Sign up to Ethos
Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.Source
Another Company
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.Source
One More Company
Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Sunt in culpa qui officia deserunt mollit anim id est laborum.Source
Nice Try
Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.Source

Sign up to Ethos to access the full customer list, plus detailed competitor and product analysis.

Sign up to Ethos